Primary |
Product Used For Unknown Indication |
51.7% |
Prostate Cancer |
35.3% |
Pain |
1.7% |
Palliative Care |
1.7% |
Vitamin Supplementation |
1.7% |
Constipation |
1.3% |
Prostate Cancer Metastatic |
1.3% |
Anticoagulant Therapy |
0.8% |
Arthropathy |
0.8% |
Hypertension |
0.8% |
Precocious Puberty |
0.8% |
Blood Testosterone |
0.4% |
Deep Vein Thrombosis |
0.4% |
Insomnia |
0.4% |
Osteoporosis |
0.4% |
Prostatic Specific Antigen Abnormal |
0.4% |
|
Urinary Retention |
16.1% |
Procedural Complication |
14.3% |
Device Breakage |
12.5% |
Oedema Peripheral |
7.1% |
Death |
5.4% |
Prostatic Specific Antigen Increased |
5.4% |
Implant Site Cellulitis |
3.6% |
Implant Site Necrosis |
3.6% |
Muscle Spasms |
3.6% |
Prostate Cancer |
3.6% |
Rash Pruritic |
3.6% |
Urinary Hesitation |
3.6% |
Vomiting |
3.6% |
Wrong Drug Administered |
3.6% |
Arthralgia |
1.8% |
Basal Ganglia Haemorrhage |
1.8% |
Bladder Cancer |
1.8% |
Cellulitis |
1.8% |
Chills |
1.8% |
Chondropathy |
1.8% |
|
Secondary |
Prostate Cancer |
52.9% |
Product Used For Unknown Indication |
41.2% |
Palliative Care |
5.9% |
|
Procedural Complication |
30.0% |
Death |
20.0% |
Heart Rate Increased |
10.0% |
Implant Site Fibrosis |
10.0% |
Prostate Cancer Recurrent |
10.0% |
Tenderness |
10.0% |
Weight Decreased |
10.0% |
|
Concomitant |
Hypertension |
14.4% |
Prostate Cancer Metastatic |
10.1% |
Diabetes Mellitus |
8.9% |
Multiple Allergies |
8.6% |
Medical Diet |
5.2% |
Cancer Hormonal Therapy |
4.6% |
Hyperlipidaemia |
4.4% |
Arteriosclerosis |
4.3% |
Cardiovascular Event Prophylaxis |
4.3% |
Coronary Artery Disease |
4.3% |
Rosacea |
4.3% |
Chronic Obstructive Pulmonary Disease |
4.0% |
Oedema Peripheral |
3.4% |
Prophylaxis |
3.2% |
Hyperuricaemia |
3.1% |
Back Pain |
2.9% |
Cancer Pain |
2.8% |
Oedema |
2.8% |
Musculoskeletal Pain |
2.5% |
Bronchitis |
2.1% |
|
Hyperuricaemia |
76.5% |
Blood Uric Acid Increased |
5.9% |
Osteonecrosis Of Jaw |
5.9% |
Diarrhoea |
2.9% |
Parkinson's Disease |
2.9% |
Squamous Cell Carcinoma |
2.9% |
Ureteric Stenosis |
2.9% |
|